- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab SC
Total 1655 results
-
Maastricht University Medical CenterCompleted
-
TakedaCompleted
-
Diabetes Care Center of Nanjing Military CommandUnknown
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
Kyowa Kirin Co., Ltd.CompletedPsoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic ErythrodermaJapan
-
StemCells, Inc.CompletedSpinal Cord Injury | Spinal Cord Trauma | Thoracic Spinal Cord Injury | Spinal Cord Injury ThoracicCanada, Switzerland
-
Northwestern UniversityNational Cancer Institute (NCI); NovartisCompletedBYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Hoffmann-La RocheCompletedRheumatoid ArthritisFrance, Germany, Italy, Spain, United Kingdom, Hong Kong, United States, Colombia, Brazil, Canada, New Zealand, South Africa, Philippines, Russian Federation, Thailand, Singapore, Bulgaria, Mexico, Australia, Lithuania, Poland, Ar... and more
-
Tufts UniversityWashington University School of Medicine; United States Agency for International... and other collaboratorsTerminated
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
National Cancer Institute (NCI)SuspendedOsteosarcoma | Recurrent OsteosarcomaUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Spain, France, Italy
-
Genentech, Inc.Completed
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
MedSIRDaiichi Sankyo, Inc.CompletedAdvanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal MetastasisSpain, Portugal
-
Fudan UniversityNot yet recruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Rowan UniversityUniversity of KentuckyRecruitingSmoking Cessation | Nicotine Dependence, Cigarettes | Acceptability of Health CareUnited States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
University of RochesterAgency for Healthcare Research and Quality (AHRQ); American Lung AssociationCompletedAsthma in ChildrenUnited States
-
Boehringer IngelheimCompletedColitis, UlcerativeSpain, United Kingdom, United States, Belgium, Germany, Italy, Austria, Canada, Japan, Korea, Republic of, Russian Federation, Poland
-
Romanian Society of NephrologyCompleted
-
Bausch Health Americas, Inc.PfizerCompletedAdvanced Illness Patients With Opioid Induced ConstipationUnited States
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
Jules Bordet InstituteWithdrawnMetastatic HER2-positive Breast Cancer With Brain Metastasis
-
Hoffmann-La RocheCompleted
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruiting
-
Genentech, Inc.No longer availableMetastatic Breast CancerUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, SystemicUnited States, Poland, Germany, Spain, Mexico, Australia, Taiwan, Argentina, Hungary
-
University of SouthamptonAstraZeneca; Natera, Inc.RecruitingGastrooesophageal CancerUnited Kingdom
-
Hoffmann-La RocheTerminated
-
Tohoku UniversityCompleted
-
The University of Hong KongNot yet recruiting
-
Bristol-Myers SquibbCompletedHealthy ParticipantsGermany
-
Saint John's Cancer InstituteTerminated
-
Novartis PharmaceuticalsCompletedAnkylosing SpondylitisJapan
-
MedImmune LLCCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingAdvanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)China
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaAustria, Belgium, Germany, Italy
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
AstraZenecaDaiichi SankyoActive, not recruitingHER2-mutant Non-Small Cell Lung CancerChina
-
George W. Sledge Jr.National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast Carcinoma | Stage III Breast CancerUnited States
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Consorzio OncotechRoche Pharma AGRecruiting